ArticleJournal of cancer research and clinical oncology2023

Bone-specific response according to MDA criteria predicts immunotherapy efficacy among advanced non-small cell lung cancer (NSCLC) patients.

Andrea De Giglio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.